NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0002-3977-60 | 0002-3977 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | CAPSULE | ORAL | 20200508 | N/A | NDA | NDA213246 | Eli Lilly and Company | SELPERCATINIB | 40 mg/1 | 60 CAPSULE in 1 BOTTLE (0002-3977-60) |
0002-2980-26 | 0002-2980 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | CAPSULE | ORAL | 20200508 | N/A | NDA | NDA213246 | Eli Lilly and Company | SELPERCATINIB | 80 mg/1 | 120 CAPSULE in 1 BOTTLE (0002-2980-26) |
0002-2980-60 | 0002-2980 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | CAPSULE | ORAL | 20200508 | N/A | NDA | NDA213246 | Eli Lilly and Company | SELPERCATINIB | 80 mg/1 | 60 CAPSULE in 1 BOTTLE (0002-2980-60) |